• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Wealthy Report
No Result
View All Result
Home Breaking News

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

by
November 19, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Summer Teen Employment

George Soros Deals a Big Blow to Tesla Rival Rivian

Saudi Billionaire Made $500 Million Russia Bet Near War’s Onset

Jeremy Grantham still expects the S&P 500 to plunge by 50% from its peak — here are 3 recession-proof stocks in his portfolio to help limit the pain

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.

Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

Next Post

Is Visa Stock A Buy After Amazon Plans To Nix Its U.K-Issued Credit Cards?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

Summer Teen Employment

by
August 14, 2022
0

Read more

Summer Teen Employment

George Soros Deals a Big Blow to Tesla Rival Rivian

Saudi Billionaire Made $500 Million Russia Bet Near War’s Onset

Jeremy Grantham still expects the S&P 500 to plunge by 50% from its peak — here are 3 recession-proof stocks in his portfolio to help limit the pain

6 Software Stocks to Buy and 4 to Sell, According to an Analyst

The ‘crying CEO’ says, ‘I’m just a small business owner — it’s not like I’ve got a fourth mansion.’

Load More

All rights reserved by www.wealthy-report.com

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.